What an honor to join the Executive Board of @bigxresearch.bsky.social! As someone living w metastatic breast cancer & connected to many other patients, I’m excited to support research that reflects what truly matters to people dealing with this disease.
🔗 bigagainstbreastcancer.org/about-big/go...
Posts by Julia Maués
On this episode of #HeartToHeart, we're joined by @itsnotpink.bsky.social of @graspcancer.bsky.social.
Julia shares her treatment journey with IC-OS President @susandent.bsky.social and treating physician Ana Barac, MD.
Tune In: tinyurl.com/bpju4ec4
🎙️It was my pleasure to speak with Dr. Erin Roesch & phenomenal patient advocate @itsnotpink.bsky.social about pregnancy associated cancer with a focus on #breastcancer, the most common cancer dx during pregnancy. #bcsm @ascocancer.bsky.social @oncoalert.bsky.social
ascopubs.org/do/pregnancy...
With ⬆️ outcomes, pts with #breastcancer have prolonged survivorship often lasting decades but may carry chronic toxicities; both ongoing tx of #MBC & long-term surveillance can add to the cumulative #financialtoxicity for #bcsm pts & families. @ascocancer.bsky.social
@oncoalert.bsky.social
#ASCO25 📖
“I have tried to live in a world that does not see color but have only succeeded in living in a world that does not see me.”
www.statnews.com/2025/01/13/k...
Patient Advocate @itsnotpink.bsky.social discusses how @therightdose.bsky.social empowers patients in their treatment decision-making & how patients can use this information to communicate with their doctors.
🎧 Listen (all channels) or 🔗 buff.ly/1o6hJNe
#PCDI #MBC #dosing #CanSky #BCSM
58 years of life with metastatic breast cancer in this photo—made possible by public investment in cancer research.
Now we’re tossing future progress down the drain with federal research cuts. 😢
#NBCCSummit #NBCConTheHill
#BecauseScience
First session of #ONSCongress on antibody drug conjugates presented by #ResearchToPractice! #ONS50 #oncsky
Continuing to Broaden Eligibility Criteria to Make #ClinicalTrials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement [Feb 9, 2021] @DrEdKim et al. @rschilsky @ASCO @CancerResrch @CCR_AACR ow.ly/jmPM50DvH0M #ctsm @FDAOncology
Amy Sherald, who painted former First Lady Michelle Obama's portrait in 2018, has a major survey of her work opening this week at the Whitney Museum of American Art in New York.
So great to finally meet in person!!
Florida @ASCO Delegation at Capitol Hill this morning for #ASCOAdvocacySummit @RManochakian @atperez_md @DevikaDasMD @Sonampuri
I am joining over 150 oncologists this week at the #ASCOAdvocacySummit in Washington, D.C. to urge Congress to help address existing #drugshortages and prevent future shortages of lifesaving and life-prolonging cancer drugs. @ascocancer.bsky.social
Great @ascocancer.bsky.social Day on the Hill today - advocating for funding for cancer care and research. Favorite meeting was with Bad Bunny, Lucy, and @repemilyrandall.bsky.social from Washington State - great supporter of access to health care for all!
An honor to meet w/ #RepGabeAmo this AM w/Drs. Mega & Strenger to discuss key #ASCOAdvocacySummit asks including consistent funding for the NIH, NCI, and ARPA-H; the Improving Seniors' Timely Access to Care Act; partnering on a
Comprehensive Solution to End Drug Shortages. @ascocancer.bsky.social
Want to join us in our efforts? Visit asco.org/actnetwork to contact your Members of Congress about the issues that matter most to you! Advocates are also on the Hill to fix #PriorAuth and protect #CancerResearch funding. #ASCOAdvocacy @ascocancer.bsky.social
An honor to meet w/Rep.Magaziner staff, Raisa Majid with Drs. Mega & Strenger to discuss key #ASCOAdvocacySummit asks including consistent funding for the NIH, NCI, and ARPA-H; the Improving Seniors' Timely Access to Care Act; partnering on a Solution to End Drug
Shortages. @ascocancer.bsky.social
Two woman in front of the capital on a windy day
🇺🇸 #ASCOAdvocacySummit with my @ascocancer.bsky.social Leadership Development Program friend Dr Shilpa Gupta. We spoke to our elected officials about issues that directly impact patients: research funding, #priorAuth, & drug shortages.
Join today w/ the ACT Network:
asco.quorum.us/action_center/
"Why would a #metastatic #cancer patient need any more stress? Why slow down the research when cancer rates are on the rise, particularly with young people under 50?” 🤦
Great questions!
#CanSky #MedSky #ScienceSky #crcsm #colorectalcancer
www.washingtonpost.com/science/2025...
"Metastatic breast cancer is the worst club with the best people." is truly a saying that resonates for so many. Watch the full video, plus all of the other presentations from our 2025 MBC Conference here: www.infinitestrength.org/blog/metasta...
“In 2023, Healio reported results of a systematic review that showed abstracts of randomized phase 3 clinical trials in gastrointestinal oncology frequently use subjective minimizing language to characterize serious toxicities.”
Once at cancer mtg where a drug was called “tolerable” from the stage w/high low-grade SE % & at least 1 grade 5, which a more experienced patient told me meant death. Also fwiw, pls partner with patients themselves, who are not mentioned as sources of knowledge here #cansky #language #patients
Watch recordings from the 2024 Breast Cancer in Young Adults Forum! 🎥
💬 Young & Strong Panel: 5 young adults share their journeys.
🎙️ Keynote: Prof. Dame Lesley Fallowfield on better doctor-patient communication.
Watch here ⬇️ youtube.com/playlist?lis...
#YoungAdultCancerAwarenessWeek
Dr. Jennifer Ligibel, a @danafarber.bsky.social breast cancer oncologist, who specializes in #ExerciseResearch, discusses how strength training can help prevent #lymphedema.
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early #BreastCancer, a discrete choice survey study recently published in the Breast Cancer Research and Treatment journal.
🔓https://pubmed.ncbi.nlm.nih.gov/39915434/
@elmayermd.bsky.social @maryamlustberg.bsky.social
Alarming #cansky stats. We need better and deeper implementation of quality metrics in healthcare to help patients get guideline concordant care wherever they seek it.
Noticeably silent amid the upheaval at HHS? Big pharma. Every new drug has NIH somewhere in its DNA--and NIH funding supports the training of their workforce. Now they're finding out FDA isn't safe, either. Wrote about how keeping quiet isn't working My latest @opinion.bloomberg.com (gift link):